Evidence map›Paper›PMID 30050506›Full record

ArticleFrontiers in microbiology2018

A New Bioactive Compound From the Marine Sponge-Derived

Srikkanth Balasubramanian, Joseph Skaf, Ulrike Holzgrabe, Richa Bharti, Konrad U Förstner, Wilma Ziebuhr, Ute H Humeida, Usama R Abdelmohsen, Tobias A Oelschlaeger

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. EditingEngineering in life sciences · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. The VirtuousAntibiotics (Basel, Switzerland) · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. International journal of molecular sciences · 2021
    Review
  13. Journal of medical microbiology · 2020
    Review
  14. Role of Interleukin-33 inFrontiers in immunology · 2020
    Article
  15. Review
  16. Frontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Srikkanth BalasubramanianInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Joseph SkafInstitute of Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Germany.
Ulrike HolzgrabeInstitute of Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Germany.
Richa BhartiCore Unit Systems Medicine, University of Würzburg, Würzburg, Germany.
Konrad U FörstnerCore Unit Systems Medicine, University of Würzburg, Würzburg, Germany.
Wilma ZiebuhrInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Ute H HumeidaGEOMAR Helmholtz Centre for Ocean Research, RD3 Marine Microbiology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Usama R AbdelmohsenDepartment of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia, Egypt.
Tobias A OelschlaegerInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
University of Würzburg · DEGEOMAR Helmholtz Centre for Ocean Research Kiel · DEMinia University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioassay-guided fractionationdevice-related infectionsmarine spongesStaphylococciStreptomycestranscriptome

Identifiers

PMID30050506
PMCPMC6050364
OpenAlexW2808502797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.